Search research articles
Contact Us
Filters
Showing results (341-350 of 527) with videos related to
Page
of 53
Sort By:
Journal of Clinical and Translational Hepatology
|
November 15, 2024
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis
Chung-Feng Huang, Konstantin Kroeniger, Chih-Wen Wang, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2011
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
Ming-Lung Yu, Chung-Feng Huang, Jee-Fu Huang, et al.
Hepatology International
|
August 12, 2009
Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand
Siwaporn Chainuvati, Jun Cheng, Jin Lin Hou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 20, 2020
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C
Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, et al.
Open Forum Infectious Diseases
|
September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus Infections
Po-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.
The Lancet. Gastroenterology & Hepatology
|
June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.
The Kaohsiung Journal of Medical Sciences
|
September 15, 2010
Viral hepatitis infections in southern Taiwan: a multicenter community-based study
Jeng-Fu Yang, Chia-I Lin, Jee-Fu Huang, et al.
Annals of Hepatology
|
October 4, 2025
A multinational survey of physician knowledge about management of chronic hepatitis C
Mohamed El-Kassas, Yusuf Yilmaz, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology
|
April 4, 2017
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
Jia-Horng Kao, Ming-Lung Yu, Cheng-Yuan Peng, et al.
The Kaohsiung Journal of Medical Sciences
|
January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
Pei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Page
of 53
Search research articles
Search
Showing results (341-350 of 527) with videos related to
Sort By:
Page
of 53
Journal of Clinical and Translational Hepatology
|
November 15, 2024
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis
Chung-Feng Huang, Konstantin Kroeniger, Chih-Wen Wang, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2011
Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
Ming-Lung Yu, Chung-Feng Huang, Jee-Fu Huang, et al.
Hepatology International
|
August 12, 2009
Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand
Siwaporn Chainuvati, Jun Cheng, Jin Lin Hou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 20, 2020
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C
Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, et al.
Open Forum Infectious Diseases
|
September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus Infections
Po-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.
The Lancet. Gastroenterology & Hepatology
|
June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.
The Kaohsiung Journal of Medical Sciences
|
September 15, 2010
Viral hepatitis infections in southern Taiwan: a multicenter community-based study
Jeng-Fu Yang, Chia-I Lin, Jee-Fu Huang, et al.
Annals of Hepatology
|
October 4, 2025
A multinational survey of physician knowledge about management of chronic hepatitis C
Mohamed El-Kassas, Yusuf Yilmaz, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology
|
April 4, 2017
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
Jia-Horng Kao, Ming-Lung Yu, Cheng-Yuan Peng, et al.
The Kaohsiung Journal of Medical Sciences
|
January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
Pei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Page
of 53